EDESA BIOTECH INC (EDSA) Fundamental Analysis & Valuation

NASDAQ:EDSA • CA27966L3065

Current stock price

6.14 USD
+0.59 (+10.63%)
At close:
6.05 USD
-0.09 (-1.47%)
After Hours:

This EDSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EDSA Profitability Analysis

1.1 Basic Checks

  • EDSA had negative earnings in the past year.
  • EDSA had a negative operating cash flow in the past year.
  • In the past 5 years EDSA always reported negative net income.
  • EDSA had a negative operating cash flow in each of the past 5 years.
EDSA Yearly Net Income VS EBIT VS OCF VS FCFEDSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of EDSA (-53.13%) is comparable to the rest of the industry.
  • With a decent Return On Equity value of -56.01%, EDSA is doing good in the industry, outperforming 60.54% of the companies in the same industry.
Industry RankSector Rank
ROA -53.13%
ROE -56.01%
ROIC N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
EDSA Yearly ROA, ROE, ROICEDSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EDSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EDSA Yearly Profit, Operating, Gross MarginsEDSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EDSA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, EDSA has more shares outstanding
  • EDSA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for EDSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EDSA Yearly Shares OutstandingEDSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
EDSA Yearly Total Debt VS Total AssetsEDSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

  • An Altman-Z score of 33.29 indicates that EDSA is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 33.29, EDSA belongs to the best of the industry, outperforming 93.42% of the companies in the same industry.
  • There is no outstanding debt for EDSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 33.29
ROIC/WACCN/A
WACCN/A
EDSA Yearly LT Debt VS Equity VS FCFEDSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

2.3 Liquidity

  • EDSA has a Current Ratio of 16.82. This indicates that EDSA is financially healthy and has no problem in meeting its short term obligations.
  • EDSA has a Current ratio of 16.82. This is amongst the best in the industry. EDSA outperforms 94.39% of its industry peers.
  • A Quick Ratio of 16.82 indicates that EDSA has no problem at all paying its short term obligations.
  • EDSA has a better Quick ratio (16.82) than 94.39% of its industry peers.
Industry RankSector Rank
Current Ratio 16.82
Quick Ratio 16.82
EDSA Yearly Current Assets VS Current LiabilitesEDSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. EDSA Growth Analysis

3.1 Past

  • EDSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.50%, which is quite impressive.
EPS 1Y (TTM)38.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • EDSA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.10% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.76%
EPS Next 2Y10.67%
EPS Next 3Y2.61%
EPS Next 5Y7.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EDSA Yearly Revenue VS EstimatesEDSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 200K 400K 600K 800K 1M
EDSA Yearly EPS VS EstimatesEDSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. EDSA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EDSA. In the last year negative earnings were reported.
  • Also next year EDSA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDSA Price Earnings VS Forward Price EarningsEDSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDSA Per share dataEDSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.67%
EPS Next 3Y2.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EDSA Dividend Analysis

5.1 Amount

  • No dividends for EDSA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDSA Fundamentals: All Metrics, Ratios and Statistics

EDESA BIOTECH INC

NASDAQ:EDSA (4/2/2026, 8:20:38 PM)

After market: 6.05 -0.09 (-1.47%)

6.14

+0.59 (+10.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-13
Earnings (Next)05-12
Inst Owners36.57%
Inst Owner Change6.12%
Ins Owners12.47%
Ins Owner Change6.46%
Market Cap51.27M
Revenue(TTM)N/A
Net Income(TTM)-7.82M
Analysts82.5
Price Target11.22 (82.74%)
Short Float %8.45%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.68%
Min EPS beat(2)-17.65%
Max EPS beat(2)39%
EPS beat(4)3
Avg EPS beat(4)7.14%
Min EPS beat(4)-17.65%
Max EPS beat(4)39%
EPS beat(8)6
Avg EPS beat(8)6.78%
EPS beat(12)10
Avg EPS beat(12)16.9%
EPS beat(16)14
Avg EPS beat(16)22.38%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.23%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.67
P/tB 4.27
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)-1.5
Fwd EYN/A
FCF(TTM)-0.95
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS0
BVpS1.67
TBVpS1.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.13%
ROE -56.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.82
Quick Ratio 16.82
Altman-Z 33.29
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y16.76%
EPS Next 2Y10.67%
EPS Next 3Y2.61%
EPS Next 5Y7.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.34%
OCF growth 3YN/A
OCF growth 5YN/A

EDESA BIOTECH INC / EDSA Fundamental Analysis FAQ

What is the fundamental rating for EDSA stock?

ChartMill assigns a fundamental rating of 3 / 10 to EDSA.


What is the valuation status of EDESA BIOTECH INC (EDSA) stock?

ChartMill assigns a valuation rating of 0 / 10 to EDESA BIOTECH INC (EDSA). This can be considered as Overvalued.


How profitable is EDESA BIOTECH INC (EDSA) stock?

EDESA BIOTECH INC (EDSA) has a profitability rating of 1 / 10.


What is the expected EPS growth for EDESA BIOTECH INC (EDSA) stock?

The Earnings per Share (EPS) of EDESA BIOTECH INC (EDSA) is expected to grow by 16.76% in the next year.